Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.
about
Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future PerspectivesAdvanced and Conventional Magnetic Resonance Imaging in Neuropsychiatric LupusNeuropsychiatric lupus: a mosaic of clinical presentationsLupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosusNeuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway.EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres.Clinical features and outcomes of posterior reversible encephalopathy syndrome in patients with systemic lupus erythematosus.Severe cognitive dysfunction and shrinking lung syndrome in systemic lupus erythematous.Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patientsTNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.Immune mediated diseases and immune modulation in the neurocritical care unitA multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus.Retinal nerve fiber layer and macular thinning in systemic lupus erythematosus: an optical coherence tomography study comparing SLE and neuropsychiatric SLE.Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.Relationship Between Clinical and Immunological Features with Magnetic Resonance Imaging Abnormalities in Female Patients with Neuropsychiatric Systemic Lupus Erythematosus.Neuropsychiatric manifestations in patients with systemic lupus erythematosus: A study from Iran.B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosusVocal cords palsy in systemic lupus erythematosus patient: diagnostic and therapeutic difficultiesIntegrative neuroscience approach to neuropsychiatric lupusA neurometabolite study of chronic daily headache in patients with systemic lupus erythematosus using magnetic resonance spectroscopy: comparison with fibromyalgia patients and healthy controls.Anti-ribosomal P antibodies related to depression in early clinical course of systemic lupus erythematosus.Alterations of white matter structural networks in patients with non-neuropsychiatric systemic lupus erythematosus identified by probabilistic tractography and connectivity-based analyses.Neuropsychiatric Systemic Lupus Erythematosus Involvement: Towards a Tailored Approach to Our Patients?Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management.Promising biomarkers for systemic lupus erythematosus.Neurology of rheumatologic disorders.Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.What can we learn from systemic lupus erythematosus pathophysiology to improve current therapy?Pharmacologic management of neuropsychiatric lupus.Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids.Diagnosing and attributing neuropsychiatric events to systemic lupus erythematosus: time to untie the Gordian knot?Successful treatment of cerebral large vessel vasculitis in systemic lupus erythematosus with intravenous pulse cyclophosphamide.Validity of the Italian algorithm for the attribution of neuropsychiatric events in systemic lupus erythematosus: a retrospective multicentre international diagnostic cohort study.Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study.Protein array autoantibody profiles to determine diagnostic markers for neuropsychiatric systemic lupus erythematosus.Central nervous system vasculitis in systemic lupus erythematosus: a case series report in a tertiary referral centre.A critical analysis of the tools to evaluate neuropsychiatric lupus.Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.Effects of sustained i.c.v. infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signalingAcute longitudinal myelitis following Cryptococcus laurentii pneumonia in a patient with systemic lupus erythematosus.
P2860
Q26774815-1B42DDFE-F1D8-4E5C-9167-207AD8EA29B2Q26799922-78B2A362-8505-4659-BAFC-FB205682EEA7Q27027588-169ACF0B-5A56-4201-804F-5D820F8FB571Q28268802-399D21C8-7854-4F74-A485-8EB7B464F521Q30727936-1EDD90E5-A488-4094-A2AD-7DC859D0409BQ30886868-9BB2E47E-BCE7-4928-9DBA-F3EBB2C4021AQ33407827-9C934441-501F-411C-9F58-44600CBC52B4Q33723612-9FE75907-36D2-4BC3-89EB-ACBF597BFA0EQ34592686-7EEDD0E6-AEEB-4E46-B2E2-045B49FE9DCFQ35688684-3B40A3CB-8CC6-43AF-85CB-AAC74E73744BQ35729575-0C563789-5B74-49F8-9899-7011A4B2B0A3Q35760387-69E76A58-A3CA-41B9-8154-E3E7B7314CB8Q36052684-B3307F58-4BB2-4B0C-8417-81987D995F27Q36484399-9F5E4C12-BE26-44E6-A60C-6303E81BA252Q36720077-C8D94CCC-2495-424B-BD27-5DE495B9DEE4Q36749976-D819AC3D-438B-486D-B36D-2C6372038176Q36774762-4FEE7FE6-4337-4CF6-A7B1-B7A1A612A2E5Q36875118-6514DC84-F238-4C48-8E25-177215DF8D53Q37032127-AF9E3AC9-9515-4090-9A4D-FAF3941D71F5Q37392464-0ED45818-4956-4B9D-B1CA-459A9123C5BCQ37498220-C6C94F03-44FD-497A-849F-C8D39C3F3B12Q37545475-A8C81E63-A169-481E-98CA-41593AC1B89BQ37632131-7A3DCA27-A06B-4667-BA77-706EA73518C7Q37922765-493433AB-8862-46BF-914D-D921CA9D3EA0Q38149960-CB6BA28A-7EB9-4CBC-AC34-7FDDFF84B76CQ38215698-24389935-989A-4CA2-881B-31B1EFDB0435Q38247180-F1066B7C-012A-404C-B7D1-DA65B2CDE5A0Q38590248-B511A86C-74B4-450C-AD0A-DF7238E016C6Q38630775-AEB95B8B-AD4C-480A-8D14-28597971DC10Q38774697-332D00ED-0F80-4008-82E8-89D74C90E3A3Q38981686-783C847B-6AFF-46FB-9ADE-AA72AB277DDFQ40170408-C79D6C6B-FF0A-4F02-B90C-DBCFCC4FD4A2Q40181738-82AB40B4-2D0E-49F4-B9F2-8AC0E347F98CQ40183545-C98865CE-17EA-4F16-883B-78C2468D996BQ40231118-52DD42A0-362A-45B6-A815-518BE91F6FA0Q40246610-EF87E625-0FAE-466A-BAF2-FF6A685F7D81Q40258144-24F67DC6-3014-4C3D-8050-5CB71584C196Q40953064-EB242DD4-7F4A-4190-A720-86A9333F6240Q41524233-8A4A5CB0-04BC-493A-8057-9360E04DAB2EQ41710244-DAE2E6A4-9A76-48AE-A624-759739802455
P2860
Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.
@ast
Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.
@en
Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.
@nl
type
label
Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.
@ast
Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.
@en
Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.
@nl
prefLabel
Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.
@ast
Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.
@en
Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.
@nl
P356
P1476
Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.
@en
P2093
Dimitrios T Boumpas
George K Bertsias
P2860
P2888
P304
P356
10.1038/NRRHEUM.2010.62
P407
P577
2010-05-11T00:00:00Z
P6179
1048665467